Goncalves RLS, Wang ZB, Riveros JK, et al. CoQ imbalance drives reverse electron transport to disrupt liver metabolism. Nature. 2025. doi:10.1038/s41586-025-09072-1
Publications
Jaehnig EJ, Fernandez-Martinez A, Vashist TD, et al. Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers. Cell reports. Medicine. 2025:102154. doi:10.1016/j.xcrm.2025.102154
Chen ASY, Kim H, Nzabarushimana E, et al. Association of distinct microbial and metabolic signatures with microscopic colitis. Nature communications. 2025;16(1):4644. doi:10.1038/s41467-025-59566-9
Poeschla M, Arora UP, Walne A, et al. Polygenic modifiers impact penetrance and expressivity in telomere biology disorders. The Journal of clinical investigation. 2025. doi:10.1172/JCI191107
Klemm N, Schimmer RR, Konrad NK, et al. The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect. Cancer research. 2025;85(11):1978-1996. doi:10.1158/0008-5472.CAN-24-1136
Flores AM, Ruan Y, Misra A, et al. Polygenic Prediction of Peripheral Artery Disease and Major Adverse Limb Events. JAMA cardiology. 2025. doi:10.1001/jamacardio.2025.1182
Sim ES, Rhoades J, Xiong K, et al. Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025:OF1-OF9. doi:10.1158/1078-0432.CCR-25-0307
Bryan ME, Aye L, Das D, et al. Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025:OF1-OF11. doi:10.1158/1078-0432.CCR-24-2525
Beck A, Gabler-Pamer L, Cruzeiro GAV, et al. Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions. Nature cancer. 2025. doi:10.1038/s43018-025-00964-9
Musunuru K, Grandinette S, Wang X, et al. Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease. The New England journal of medicine. 2025. doi:10.1056/NEJMoa2504747